Abstract
Neurosyphilis continues to be a difficult diagnosis for clinicians. The decision to perform a lumbar puncture, interpretation of cerebrospinal fluid findings, clear diagnostic guidelines, establishment of definitive therapy (including alternatives to penicillins), and approach to the follow-up of patients with neurosyphilis are all areas that pose ongoing challenges to clinicians. Coinfection with HIV has also further complicated the already challenging arena of neurosyphilis presentation, diagnosis, and management. Clinicians must recognize the recent changes in the epidemiology of syphilis and know when to initiate appropriate screening. This article highlights the limitations and controversies related to neurosyphilis diagnosis and treatment, and current recommendations on management of patients with neurosyphilis, including those coinfected with HIV.
Similar content being viewed by others
References and Recommended Reading
Merritt HH, Adams RD, Solomon HC: Neurosyphilis. New York: Oxford University Press; 1946.
Centers for Disease Control and Prevention, National Center for HIV, STD, and TB Prevention, Division of STDs: Sexually Transmitted Diseases Surveillance 2001. Atlanta, GA: Centers for Disease Control and Prevention; 2002.
Whiteside CM: Persistence of neurosyphilis despite multiple treatment regimens. Am J Med 1989, 87:225–227.
Musher DM, Hamill RJ, Baugh RE: Effect of human immunodeficiency virus infection on the course of syphilis and on the response to treatment. Ann Intern Med 1990, 113:872–881.
Katz DA, Berger JR: Neurosyphilis in acquired immunodeficiency syndrome. Arch Neurol 1989, 46:895–898.
Gordon SM, Eaton ME, George R, et al.: The response of symptomatic neurosyphilis to high dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med 1994, 331:1469–1473.
Brandt AM: Shadow on the land. In No Magic Bullet: A Social History of Venereal Disease in the United States Since 1880. New York: Oxford University Press; 1987.
Ciesielski CA: Sexually transmitted diseases in men who have sex with men: an epidemiologic review. Curr Infect Dis Rep 2003, 5:145–157.
Sexually transmitted diseases in men who have sex with men--New York City, 2001. MMWR Morb Mortal Wkly Rep 2002, 51:853–856.
Transmission of primary and secondary syphilis by oral sex--Chicago, Illinois 1998–2002. MMWR Morb Mortal Wkly Rep 2004, 53:966–968.
Lukehart SA, Hook EW 3rd, Baker-Zander SA, et al.: Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988, 109:855–862.
Golden MR, Marra CM, Holmes KK: Update on syphilis: resurgence of an old problem. JAMA 2003, 290:1510–1514. This is a succinct recent overview of syphilis in the United States today.
Tramont EC: Syphilis in adults: from Christopher Columbus to Sir Alexander Fleming to AIDS. Clin Infect Dis 1995, 21:1361–1371.
Tramont EC: Neurosyphilis. http://pier.acponline.org/ physicians/diseases/d777/d777.html. Accessed March 23, 2005.
Ances BM, Shellhaus R, Brown MJ, et al.: Neurosyphilis and status epilepticus: case report and literature review. Epilepsy Res 2004, 59:67–70.
Jacquemin GL, Proulx P, Gilbert DA, et al.: Functional recovery from paraplegia caused by syphilitic meningomyelitis. J Spinal Cord Med 2002, 25:133–137.
Becker GD: Late syphilitic hearing loss: a diagnostic and therapeutic dilemma. Laryngoscope 1979, 89:1273–1288.
Rolfs RT, Joesoef MR, Hendershot EF, et al.: A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection: the Syphilis and HIV study group. N Engl J Med 1997, 337:307–314. This is the largest randomized prospective treatment trial for syphilis ever published. This article provides great insights into early syphilis infection and the effect it has on the CSF.
Rompalo AM, Joesoef MR, O’Donnell JA, et al.: Clinical manifestations of early syphilis by HIV status and gender: results of the Syphilis and HIV study. Sex Transm Dis 2001, 28:158–165. This study is a more detailed analysis of some of the results of Rolfs et al. [18••].
Sexually Transmitted Diseases Treatment Guidelines 2002: Centers for Disease Control & Prevention. MMWR Recomm Rep 2002, 51:1–78. Every clinician should have a copy of the most recent treatment guidelines. These are usually updated every 4 to 5 years.
Marra CM, Maxwell CL, Smith SL, et al.: Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004, 189:369–376. This is a very interesting study that looks further at what, if any, clinical data points may be helpful regarding the need for lumbar puncture in guiding clinicians who care for patients with syphilis.
van der Valk PGM, Kraai EJ, van Voorst Vadev PC, et al.: Penicillin concentrations in cerobrospinal fluid during repository treatment regimen for syphilis. Genitourin Med 1988, 64:223–225.
Scheck DN, Hook EW 3rd: Neurosyphilis. Infect Dis Clin North Am 1994, 8:769–790.
Chan DJ: Syphilis and HIV co-infection: when is lumbar puncture indicated? Curr HIV Res 2005, 3:95–98.
Norris SJ, Popee VP, Johnson RE, Larsen SA: Treponema and other host-associate spirochetes. In Manual of Clinical Microbiology, edn 8. Edited by Murray PR, Barron EJ, Jorgensen JH, et al. Washington, DC: ASM Press; 2003:955–971.
Larsen SA, Stiener BM, Rudolph AL: Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev 1995, 8:1–21. Although this review is 10 years old, it is the best and most comprehensive in the literature, and well worth reviewing.
Peter JB: Treponema pallidum. In Use and Interpretation of Laboratory Tests in Infectious Diseases, edn 6. Edited by Peter JB. Santa Monica, CA: Specialty Laboratories; 2000:256–257.
Participant Summary. G-C Syphilis Serology Survey. Chicago, IL: College of American Pathologists; 2004:1–17.
Marra CM, Critchlow CW, Hook EW 3rd, et al.: Cerebrospinal fluid treponemal antibodies in untreated early syphilis. Arch Neurol 1995, 52:68–72.
Luger AF, Schmidt BL, Kaulich M: Significance of laboratory findings for diagnosis of neurosyphilis. Int J STD AIDS 2000, 22:224–234.
Grimpel EP, Sanchez PJ, Wendel GD, et al.: Use of polymerase chain reaction and rabbit infectivity testing to detect Treponema pallidum in amniotic fluid. J Clin Microbiol 1991, 29:1711–1718.
Noordhoek DT, Wolters EC, De Jonge MEJ, van Embden JDA: Detection by polymerase chain reaction of Treponema pallidum DNA in cerebrospinal fluid from neurosyphilis patients before and after antibiotic therapy. J Clin Microbiol 1991, 29:1976–1984.
Liu H, Rodes B, Chen CY, Steiner B: New tests for syphilis: rational design of a PCR method for detection of Treponema pallidum in clinical specimens using unique regions of the DNA polymerase 1 gene. J Clin Microbiol 2001, 39:1941–1946.
Collier AC, Marra CM, Coombs RW, et al.: Central nervous system manifestations in HIV and AIDS. J Acquir Immune Defic Syndr 1992, 5:229–241.
Marshall DW, Brey RL, Cahill WT, et al.: Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 1988, 45:954–958.
Onoda Y: Therapeutic effect of oral doxycycline in syphilis. Br J Vener Dis 1979, 55:110–115.
Yim CW, Flynn NM, Fitzgerald PT: Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis. Antimicrob Agents Chemother 1985, 28:347–348.
Johnson RC, Bey RF, Wolgamot SJ: Comparison of the activities of ceftriaxone and penicillin against experimentally induced syphilis in rabbits. Antimicrob Agents Chemother 1982, 21:984–989.
Marra CM, Slatter V, Tartaglione TA, et al.: Evaluation of aqueous penicillin G and ceftriaxone for experimental neurosyphilis [letter]. J Infect Dis 1992, 165:346–347.
Schofer H, Vogt HJ, Milbradt R: Ceftriaxone for treatment of primary and secondary syphilis. Chemotherapy 1989, 35:440–445.
Dowell ME, Ross PG, Musher DM, et al.: Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 1992, 93:481–488.
Marra CM, Boutin P, MCArthur JL, et al.: A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in HIV-infected individuals. Clin Infect Dis 2000, 30:540–544.
Smith NH, Musher DM, Huang DB, et al.: Response of HIV-infected patients with asymptomatic neurosyphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int J STD AIDS 2004, 15:328–332.
Pao D, Goh BT, Bingham JS: Management issues in syphilis. Drugs 2002, 62:1447–1461. This is a good review of the current management of the various stages of syphilis. The authors are from the United Kingdom and present the European approach to syphilis in a comprehensive fashion.
Marra CM, Maxwell CL, Tantalo L, et al.: Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter? Clin Infect Dis 2004, 38:1001–1006.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O’Donnell, J.A., Emery, C.L. Neurosyphilis: A current review. Curr Infect Dis Rep 7, 277–284 (2005). https://doi.org/10.1007/s11908-005-0060-7
Issue Date:
DOI: https://doi.org/10.1007/s11908-005-0060-7